IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market

Core Viewpoint - Baron Focused Growth Fund demonstrated strong performance in Q4 2025, significantly outperforming the Russell 2500 Growth Index, with a return of 12.34% compared to the index's 0.33% [1] Group 1: Fund Performance - The Fund achieved a total return of 22.26% in 2025, while the Russell 2500 Growth Index returned 10.31% [1] - As of December 31, 2025, the top 10 positions of the Fund accounted for 60.1% of net assets [1] Group 2: IDEXX Laboratories, Inc. Overview - IDEXX Laboratories, Inc. is a leading US-based healthcare company focused on diagnostics for the veterinary industry, benefiting from an increase in pet ownership during the COVID pandemic [3] - As of February 4, 2026, IDEXX's stock closed at $642.94 per share, with a market capitalization of $51.438 billion [2] - The stock experienced a -9.75% return in the past month but has increased by 39.60% over the past twelve months [2] Group 3: Investment Sentiment - IDEXX Laboratories, Inc. was held by 55 hedge fund portfolios at the end of Q3 2025, an increase from 48 in the previous quarter [4] - Despite recognizing IDEXX's potential, there is a belief that certain AI stocks may offer greater upside potential with less downside risk [4]